197 related articles for article (PubMed ID: 22988968)
1. Arsenic trioxide-induced growth arrest of breast cancer MCF-7 cells involving FOXO3a and IκB kinase β expression and localization.
Liu W; Gong Y; Li H; Jiang G; Zhan S; Liu H; Wu Y
Cancer Biother Radiopharm; 2012 Oct; 27(8):504-12. PubMed ID: 22988968
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.
Fei M; Lu M; Wang Y; Zhao Y; He S; Gao S; Ke Q; Liu Y; Li P; Cui X; Shen A; Cheng C
Med Oncol; 2009; 26(2):178-85. PubMed ID: 18937079
[TBL] [Abstract][Full Text] [Related]
3. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.
Li X; Ding X; Adrian TE
Cancer Invest; 2004; 22(3):389-400. PubMed ID: 15493360
[TBL] [Abstract][Full Text] [Related]
5. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer.
Xia J; Li Y; Yang Q; Mei C; Chen Z; Bao B; Ahmad A; Miele L; Sarkar FH; Wang Z
Int J Mol Sci; 2012; 13(8):9627-9641. PubMed ID: 22949821
[TBL] [Abstract][Full Text] [Related]
7. Arsenic Trioxide Promotes Paclitaxel Cytotoxicity in Resistant Breast Cancer Cells.
Bakhshaiesh TO; Armat M; Shanehbandi D; Sharifi S; Baradaran B; Hejazi MS; Samadi N
Asian Pac J Cancer Prev; 2015; 16(13):5191-7. PubMed ID: 26225652
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and pro-apoptotic effects of three fungal exocellular β-glucans in MCF-7 breast cancer cells is mediated by oxidative stress, AMP-activated protein kinase (AMPK) and the Forkhead transcription factor, FOXO3a.
Queiroz EA; Fortes ZB; da Cunha MA; Barbosa AM; Khaper N; Dekker RF
Int J Biochem Cell Biol; 2015 Oct; 67():14-24. PubMed ID: 26255117
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH
Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917
[TBL] [Abstract][Full Text] [Related]
11. Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide.
Wang X; Gao P; Long M; Lin F; Wei JX; Ren JH; Yan L; He T; Han Y; Zhang HZ
Med Oncol; 2011 Dec; 28(4):1225-54. PubMed ID: 20458559
[TBL] [Abstract][Full Text] [Related]
12. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR
J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.
Sunters A; Madureira PA; Pomeranz KM; Aubert M; Brosens JJ; Cook SJ; Burgering BM; Coombes RC; Lam EW
Cancer Res; 2006 Jan; 66(1):212-20. PubMed ID: 16397234
[TBL] [Abstract][Full Text] [Related]
14. 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells.
Sharma G; Kar S; Palit S; Das PK
J Cell Physiol; 2012 May; 227(5):1923-31. PubMed ID: 21732363
[TBL] [Abstract][Full Text] [Related]
15. BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells.
Yuan Z; Wang F; Zhao Z; Zhao X; Qiu J; Nie C; Wei Y
PLoS One; 2011; 6(5):e20586. PubMed ID: 21655183
[TBL] [Abstract][Full Text] [Related]
16. Arsenic hexoxide enhances TNF-α-induced anticancer effects by inhibiting NF-κB activity at a safe dose in MCF-7 human breast cancer cells.
Kim MJ; Jung JH; Lee WS; Yun JW; Lu JN; Yi SM; Kim HJ; Chang SH; Kim GS; Hong SC; Ha WS
Oncol Rep; 2014 May; 31(5):2305-11. PubMed ID: 24627159
[TBL] [Abstract][Full Text] [Related]
17. Critical Role of AMPK/FoxO3A Axis in Globular Adiponectin-Induced Cell Cycle Arrest and Apoptosis in Cancer Cells.
Shrestha A; Nepal S; Kim MJ; Chang JH; Kim SH; Jeong GS; Jeong CH; Park GH; Jung S; Lim J; Cho E; Lee S; Park PH
J Cell Physiol; 2016 Feb; 231(2):357-69. PubMed ID: 26089158
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro.
Lin LM; Li BX; Xiao JB; Lin DH; Yang BF
World J Gastroenterol; 2005 Sep; 11(36):5633-7. PubMed ID: 16237756
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
20. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]